Current stock page

Catalysts

EWTX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

EWTXEdgewise Therapeutics, Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$45.93+$0.11 (+0.24%)

Latest quote

  • Momentum
    82
  • Value
    —
  • Quality
    68
  • Risk resilience
    57
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 25, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 72/100

Momentum 82/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 48.46%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 82/100AIQ Edge 10/10 Sector Leader
Beat rate
63%
5 of 8 reported periods
Average surprise
+239.7%
Across covered historical reports
Latest result
+1914.0%
Nov 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—-$0.53$9.65+1914.0%$119.23M—
Aug 6, 2026—-$0.47-$0.53-13.3%——
May 7, 2026—-$0.50-$0.46+8.0%——
Feb 26, 2026—-$0.43-$0.47-9.3%——
Nov 6, 2025—-$0.40-$0.39+2.5%——
Aug 7, 2025—-$0.42-$0.34+19.0%——
May 8, 2025—-$0.45-$0.43+4.4%——
Mar 3, 2025—-$0.39-$0.42-7.7%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
12
Buy
1
Hold
12-month analyst target
$71.00
+54.58% versus current price
Based on 13 analyst observations. Targets are estimates, not predictions.
Low target
$57.00
+24.10% vs latest price
Average target
$71.00
+54.58% vs latest price
High target
$85.00
+85.06% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 25, 2027

Next known earnings or reporting date.

EPS estimate-$0.43

Current analyst expectation for the upcoming report.

Revenue estimate$9.62M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score82

Where event reaction would show up first.

AIQ score72/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
13
Average target
$71.00
Target upside
54.58%
Target range
$57.00 - $85.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
0
Negative
0
gurufocus.com · Nov 7, 2026

Edgewise Therapeutics (EWTX) Stock Rises 12% Amid Acquisition Interest

On November 07, 2026, Edgewise Therapeutics Inc (EWTX) saw its shares climb 12% following reports that the biopharmaceutical company has engaged advisers to exp

seekingalpha.com · Nov 6, 2026

Edgewise Therapeutics gains amid report of takeover interest (EWTX:NASDAQ)

Edgewise Therapeutics jumps on takeover interest reports.

gurufocus.com · Oct 16, 2026

EWTX Initiated Coverage by William Blair -- Rating Set to Outperform

Edgewise Therapeutics (EWTX) Analyst Rating Update On October 16, 2026, Edgewise Therapeutics (EWTX) received a new analyst rating from William Blair, who in

gurufocus.com · Sep 29, 2026

ORBIMED ADVISORS LLC Acquires 6,885,170 Shares of Electra Therapeutics Inc (ETRA) Following IPO

A Swift Post-IPO Entry by a Healthcare Specialist On Sept. 21, 2026, ORBIMED ADVISORS LLC (Trades, Portfolio) initiated a new holding of 6,885,170 shares in Ele

Open full news and sentiment

EWTX Catalysts FAQ

What are the next catalysts for EWTX stock?

EWTX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move EWTX stock?

Upcoming events that could move EWTX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could EWTX's next earnings report affect the stock?

EWTX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive EWTX stock higher?

EWTX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt EWTX stock?

EWTX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.